1Simonart T, Boelaert JR, Mosselmans R, et al. Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells. Gynecol Oncol, 2002,85:95-102.
2Tanaka T, Satoh T, Onozawa Y, et al. Apoptosis during iron chelator-induced differentiation in F9 embryonal carcinoma cells. Cell Biol Int, 1999,23:541-550.
3Buss JL, Neuzil J, Gellert N, et al. Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties. Biochem Pharmacol, 2003,65:161-172.
4Marchetti P, Castedo M, Susin SA, et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med, 1996,184:1155-1160.
5Jiang XP, Wang F, Yang DC, et al. Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo . Anticancer Res , 2002 ,22:2685-2692.
8Meggiato T, Calabrese F, De Cesare CM, et al. C-JUN and CPP32 (CASPASE 3) in human pancreatic cancer: relation to cell proliferation and death[J]. Pancreas, 2003, 26(1): 65-70.
9Roy S, Bayly CI, Gareau Y, et al. Maintenance of caspasc-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide[J]. Proc Natl Acad Sci USA, 2001, 98 (11):6132 -6137.
10Yang R, Muller C, Huynh V, et al. Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins[J]. Mol Cell Biol, 1999, 19(3): 2400- 2407.
